CellCarta and Pillar Biosciences Form a Strategic Alliance for Oncology Clinical Trials CellCarta and Pillar Biosciences have partnered to enhance decentralized tumor profiling in oncology trials. This strategic move streamlines processes and supports rapid enrollment.

CellCarta and Pillar Biosciences Form a Strategic Alliance for Oncology Clinical Trials #Canada #Montreal #CellCarta #Pillar_Biosciences #Oncology_Trials

Lunit and CellCarta Forge Alliance to Enhance AI-Driven Digital Pathology in Biopharma Lunit and CellCarta have joined forces to accelerate AI-enabled digital pathology workflows, enhancing companion diagnostics in biopharma.

Lunit and CellCarta Forge Alliance to Enhance AI-Driven Digital Pathology in Biopharma #South_Korea #Seoul #Lunit #CellCarta #AI_Pathology

CellCarta and Biofidelity Forge Exclusive Partnership for Aspyre® Lung Testing CellCarta and Biofidelity have expanded their partnership to exclusively offer Aspyre® Lung for targeted lung cancer testing, streamlining clinical trials.

CellCarta and Biofidelity Forge Exclusive Partnership for Aspyre® Lung Testing #Cambridge #United_Kingdom #Biofidelity #CellCarta #Aspyre_Lung

CellCarta Hires Dr. Ehab A. El-Gabry to Boost AI and CDx Strategy Dr. Ehab A. El-Gabry joins CellCarta as Chief Medical Officer to lead advancements in digital pathology and companion diagnostics for enhanced patient care.

CellCarta Hires Dr. Ehab A. El-Gabry to Boost AI and CDx Strategy #Canada #Montreal #Chief_Medical_Officer #CellCarta #Ehab_A._El-Gabry

Slope and CellCarta Solidify Partnership to Enhance Lab Kit Management and Reduce Waste Slope and CellCarta announce a formal partnership to streamline lab kit management, cutting waste significantly and enhancing clinical trial logistics.

Slope and CellCarta Solidify Partnership to Enhance Lab Kit Management and Reduce Waste #United_States #Richmond #Slope #CellCarta #Lab_Management

Lunit and CellCarta Forge Global Alliance to Enhance Access to Digital Pathology AI in Clinical Trials Lunit and CellCarta have established a strategic partnership aimed at integrating AI-powered pathology solutions in clinical trials, improving access and efficiency.

Lunit and CellCarta Forge Global Alliance to Enhance Access to Digital Pathology AI in Clinical Trials #South_Korea #Seoul #Lunit #Digital_Pathology #CellCarta

Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials - PharmaTimes New partnership to advance precision medicine in lung cancer diagnosis

#genomicsolutions #MolecularDiagnostics #Biofidelity #oncology #genomics4all #CellCarta #AspyreLung #precisionmedicine #nonsmallcelllungcancer #NSCLC #NSCLCbiomarkers #genomicservices #clinicaltrialenrolment #SimplifiedGenomicProfiling #SGP #qPCRplatforms
pharmatimes.com/news/biofide...

Biofidelity and CellCarta's Innovative Approach to Clinical Trials Launching Aspyre® Lung Biofidelity partners with CellCarta to implement Aspyre® Lung in global clinical trials, advancing cancer diagnosis with innovative genomic solutions.

Biofidelity and CellCarta's Innovative Approach to Clinical Trials Launching Aspyre® Lung #Cambridge #United_Kingdom #Biofidelity #CellCarta #Aspyre_Lung